✦ LIBER ✦

O163 TURQUOISE-II: SVR12 RATES OF 92–96% IN 380 HEPATITIS C VIRUS GENOTYPE 1-INFECTED ADULTS WITH COMPENSATED CIRRHOSIS TREATED WITH ABT-450/R/ABT-267 AND ABT-333 PLUS RIBAVIRIN (3D+RBV)

✍ Scribed by Poordad, F.; Hezode, C.; Trinh, R.; Kowdley, K.V.; Zeuzem, S.; Agarwal, K.; Shiffman, M.L.; Wedemeyer, H.; Berg, T.; Yoshida, E.M.; Forns, X.; Lovell, S.S.; Da Silva-Tillmann, B.; Campbell, A.L.; Podsadecki, T.

Book ID: 122237654
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 152 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61458-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu2039 TURQUOISE-II: SVR12 Rates of 92%-

Tu2039 TURQUOISE-II: SVR12 Rates of 92%-96% in 380 Hepatitis C Virus Genotype 1-Infected Adults with Compensated Cirrhosis Treated with ABT-450/r/ABT-267 and ABT-333 plus Ribavirin (3D+RBV)

✍ Kowdley, Kris V.; Poordad, Fred; Trinh, Roger; Hezode, Christophe; Zeuzem, Stefa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Su1061 Pearl-IV: a 12-Week Regimen of AB

Su1061 Pearl-IV: a 12-Week Regimen of ABT-450/r/ABT-267 and ABT-333, With or Without Ribavirin Achieves Svr12 Rates≥90% in Treatment-Naïve Adults Infected With Hepatitis C Virus Genotype 1A

✍ Bernstein, David; Lalezari, Jacob; Luo, Yan; Box, Terry D.; Younes, Ziad H.; Gre 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 544 KB

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLL

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN TREATMENT-EXPERIENCED ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Zeuzem, S.; Jacobson, I.; Baykal, T.; Marinho, R.T.; Poordad, F.; Bourliere, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 152 KB

235 SAPPHIRE II: Phase 3 Placebo-Control

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

✍ Jacobson, Ira M.; Zeuzem, Stefan; Baykal, Tolga; Marinho, Rui T.; Poordad, Fred; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 361 KB

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLL

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAIVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Feld, J.J.; Kowdley, K.V.; Coakley, E.; Sigal, S.; Nelson, D.; Crawford, D.; Wei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB